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Objective: This study assessed the performance of pulse oxi-
metry as a screening method for the detection of critical
congenital heart defects (CHD) in asymptomatic newborn
babies.
Background: Screening for critical congenital heart defects
in newborn babies can aid in early recognition, which may
lead to improved outcome. The potential predictive value of
using pulse oximetry to screen for significant cyanotic CHD in
newborns has been unclear. One difficulty of determining the
potential value of universal screening of newborns with pulse
oximetry from previous studies is that the relative infre-
quency of CHD made any individual study less able to
demonstrate benefit. This meta-analysis with 229,421
newborn babies makes this a more powerful study.
Methods: In this meta-analysis, the authors searched
Medline (1951e2011), Embase (1974e2011), Cochrane Library
(2011), and SciSearch (1974e2011) for studies that assessed the
accuracy of pulse oximetry for the detection of critical CHD in
asymptomatic newborn babies. Two reviewers selected
studies that met the predefined criteria for population, tests,
and outcomes, and sensitivity, specificity, and corresponding
95% CIs for individual studies were determined.
Results: Thismeta-analysis identified 13 studies, published
from 2001 to 2011, that screened 229,421 asymptomatic
newborn infants for critical CHD (defined as disorders from
which infants died or required invasive procedures or surgery
in the first 28 days of life). The overall sensitivity of pulse
oximetry for detection of critical CHD was 76.5%. The speci-
ficity was 99.9%, with a false-positive rate of 0.14%.
Measurementofpulseoximetrybefore24 hofage improved
sensitivity from 77.5% to 84.8% (a nonsignificant difference)
but increased the false-positive rate from 0.05% to 0.5% (a
significantdifference; p¼ .0017). Locationof thepulseoximeter
probe did not affect sensitivity or the frequency of false-
positive results. Thangaratinam and colleagues concluded
that pulse oximetry is a highly specific test for detection of
critical CHD in newborn infants, and that the false-positive
rate is low, especially when done after 24 h of age.
Conclusion: Pulse oximetry is highly specific and moder-
ately sensitive for detection of critical CHD and it meets the
criteria for universal screening.
Clinical perspective
Pulse oximetry screening can lead to the early detection of
lesions such as coarctation of the aorta, interrupted aortic
arch, transposition of the aorta, aortic and pulmonary
stenosis, tetralogy of Fallot, pulmonary atresia and total
anomalous pulmonary venous connection. Early correction of
these lesions before the onset of acidosis and decompensation
can lead to an improved outcome.
The American Academy of Pediatrics endorsed universal
newborn screening with pulse oximetry earlier this year and
stated that screening should be performed after 24 h of age
and should include readings from both the right hand andeither foot. They recommend a “pass” oxygen saturation level
of 95%, repeat screens at oxygen saturations of 90%e95%, and
immediate evaluation in infants whose pulse oximetry read-
ings are less than 90%.
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Summary of ROMICAT II study
The ROMICAT II study was a multi-centric study aimed to
evaluate the effectiveness of coronary computed tomographic
angiography (CCTA) in suspected patients of acute coronary
syndrome (ACS) seen in the emergency room (ER). Eligibility
criteria were patients with acute chest pain not showing
ischemic changes in the ECG and having normal troponin
levels. Out of a total 1000 acute chest patients enrolled, 501
were randomly assigned to the investigation group where
CCTA, performed as early as possible, was the first diagnostic
test. The remaining 499 patients were given standard emer-
gency room care. The following end points were compared in
the two groups, both at baseline and after 28 days: (i) duration
of hospitalization (ii) time to diagnosis (iii) direct discharge
rate from ER (iv) re-hospitalization after 28 days (v) adverse
cardiac events after 28 days.
A total 8% patients with acute chest pain had acute coro-
nary syndrome (mean age 54  8, male 53%) .When compared
to patients receiving standard evaluation, patients under-
going CCTA were observed to have shorter hospital stay
(reduced by 7.6 h, P < 0.001), duration of hospitalization
(23.2  37.0 h vs. 30.8  28.0 h, P < 0.001), and a higher inci-
dence of discharge done directly from the emergency room
(47% vs. 12%, P < 0.001). The incidence of adverse cardiac
events and re-hospitalization, and the cost of care ($4289 (Rs.
239540) vs. $ 4060 (Rs. 226751)), were found to be comparable
in the two groups.
Emergency use of CCTA in ACS patients, reduced the time
to diagnosis by quicker exclusion of CAD, leading to faster
discharge (done directly from ER) and lesser need for hospital
admission at the initial presentation (30% vs. 60%, P, 0.001).
The overall morbidity and readmission rates (at 1 month) and
cost of care were however not reduced. Significantly, in
patients in whom ACS was diagnosed, duration of hospitali-
zationwas similar in the two groups (86.3 72.3 vs. 83.8 61.3,
P ¼ 0.87).
Clinical perspective
The ROMICAT II study shows that in patients presenting with
acute chest pain, use of coronary computed tomography
